儘管隨機對照試驗被認為是新藥批准的標準研究方法, 但仍無法檢測到所有不良藥物事件.
由於許多嚴重的藥物不良反應, 許多藥物在市場批准後仍被撤回. 因此, 藥品核可後 …

Background: Oral anticoagulant (OAC) for atrial fibrillation use remains underutilized despite
evidence in favor of its utility. In a three-center study examining the efficacy of a …

Introduction: Although implantable cardiac monitors (ICM) improve atrial fibrillation (AF)
detection relative to Holters or other extended ambulatory cardiac monitors (EACMs)(eg, 30 …

A major goal in management of adults with atrial fibrillation (AF) is prevention of stroke. In an
editorial, our stroke neurology colleagues 1 point out that about 1/3 of patients with an AF …

Background After the advent of oral anticoagulants (OAC), how to increase medication
adherence is crucial for determining patients' prognosis. In previous randomized controlled …

抄録< jats: title> Summary</jats: title>< jats: p> Efforts to reduce stroke in atrial fibrillation
(AF) have focused on increasing physician adherence to oral anticoagulant (OAC) …

Abstract Funding Acknowledgements Type of funding sources: Private company. Main
funding source (s): Medtronic OnBehalf Reveal LINQ Registry Investigators Background …

Background Despite ample clinical trial data demonstrating that oral anticoagulation (OAC)
treatment is highly effective in reducing stroke for patients with atrial fibrillation (AF), OAC …

Background Atrial fibrillation (AF) is the most common significant cardiac rhythm disorder
and is a powerful common risk factor for stroke. Randomized trials have demonstrated that …

NOACs for stroke prevention in atrial fibrillation AF is the most common sustained arrhythmia
and its prevalence increases with advancing age, with more than onethird of patients being …